Surrogate end points in women's health research: science, protoscience, and pseudoscience
- PMID: 20153470
- DOI: 10.1016/j.fertnstert.2009.12.054
Surrogate end points in women's health research: science, protoscience, and pseudoscience
Abstract
A surrogate end point (e.g., a laboratory test or image) serves as a proxy for a clinical end point of importance (e.g., fracture, thrombosis, or death). Adoption and use of surrogate end points lacking validation, especially in cardiovascular medicine, have caused thousands of patients' deaths, a serious violation of the ethical principle of beneficence.
Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Surrogate end points in clinical research: hazardous to your health.Obstet Gynecol. 2005 May;105(5 Pt 1):1114-8. doi: 10.1097/01.AOG.0000157445.67309.19. Obstet Gynecol. 2005. PMID: 15863552 Review.
-
State of the heart: building science to improve women's cardiovascular health.Am J Crit Care. 2006 Nov;15(6):556-66; quiz 567. Am J Crit Care. 2006. PMID: 17053263 Review.
-
[Feministic research means that all research is political].Lakartidningen. 2000 Nov 22;97(47):5477-81. Lakartidningen. 2000. PMID: 11192773 Review. Swedish.
-
The women's health movement: political, social, and medical issues.Am Pharm. 1994 Dec;NS34(12):30-5. Am Pharm. 1994. PMID: 7856506 No abstract available.
-
State of the heart: building science to improve women's cardiovascular health.Commun Nurs Res. 2006 Spring;39:33-50. Commun Nurs Res. 2006. PMID: 16729516 Review. No abstract available.
Cited by
-
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.Drugs R D. 2011;11(2):159-70. doi: 10.2165/11591200-000000000-00000. Drugs R D. 2011. PMID: 21679006 Free PMC article. Clinical Trial.
-
New and emerging contraceptives: a state-of-the-art review.Int J Womens Health. 2014 Feb 19;6:221-34. doi: 10.2147/IJWH.S46811. eCollection 2014. Int J Womens Health. 2014. PMID: 24570597 Free PMC article. Review.
-
Estrogen and thrombosis: controversies and common sense.Rev Endocr Metab Disord. 2011 Jun;12(2):77-84. doi: 10.1007/s11154-011-9178-0. Rev Endocr Metab Disord. 2011. PMID: 21559819 Review.
-
Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.Clin Drug Investig. 2011;31(8):573-584. doi: 10.2165/11590220-000000000-00000. Clin Drug Investig. 2011. PMID: 21721593 Clinical Trial.
-
Progestin-only pills for contraception.Cochrane Database Syst Rev. 2013 Nov 13;2013(11):CD007541. doi: 10.1002/14651858.CD007541.pub3. Cochrane Database Syst Rev. 2013. PMID: 24226383 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical